Abstract
Background
Skeeter syndrome is a severe local allergic response to mosquito bites that is accompanied by considerable inflammation and, in some cases, a systemic response like fever. People with the syndrome develop serious allergies, ranging from rashes to anaphylaxis or shock. The few available studies on mosquito venom immunotherapy have utilized whole-body preparations and small sample sizes. Still, owing to their little success, vaccination remains a promising alternative as well as a permanent solution for infections like Skeeter’s.
Methods
This study, therefore, illustrated the construction of an epitope-based vaccine candidate against Skeeter Syndrome using established immunoinformatic techniques. We selected three species of mosquitoes, Anopheles melas, Anopheles funestus, and Aedes aegypti, to derive salivary antigens usually found in mosquito bites. Our construct was also supplemented with bacterial epitopes known to elicit a strong TH1 response and suppress TH2 stimulation that is predicted to reduce hypersensitivity against the bites.
Results
A quality factor of 98.9496, instability index of 38.55, aliphatic index of 79.42, solubility of 0.934747, and GRAVY score of -0.02 indicated the structural (tertiary and secondary) stability, thermostability, solubility, and hydrophilicity of the construct, respectively. The designed Aedes–Anopheles vaccine (AAV) candidate was predicted to be flexible and less prone to deformability with an eigenvalue of 1.5911e-9 and perfected the human immune response against Skeeter (hypersensitivity) and many mosquito-associated diseases as we noted the production of 30,000 Th1 cells per mm3 with little (insignificant production of Th2 cells. The designed vaccine also revealed stable interactions with the pattern recognition receptors of the host. The TLR2/vaccine complex interacted with a free energy of − 1069.2 kcal/mol with 26 interactions, whereas the NLRP3/vaccine complex interacted with a free energy of − 1081.2 kcal/mol with 16 molecular interactions.
Conclusion
Although being a pure in-silico study, the in-depth analysis performed herein speaks volumes of the potency of the designed vaccine candidate predicting that the proposition can withstand rigorous in-vitro and in-vivo clinical trials and may proceed to become the first preventative immunotherapy against mosquito bite allergy.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig8_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig9_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig10_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11686-023-00771-1/MediaObjects/11686_2023_771_Fig11_HTML.png)
Similar content being viewed by others
Data availability
All the data generated in this research work has been included in the manuscript.
References
Matsumoto K (2021) Valuable lessons from analyses of common signs and symptoms in rare diseases. Allergol Int 70:405–406. https://doi.org/10.1016/j.alit.2021.08.011
Abdel Motagaly A, Mohammad H, Morsy T (2017) A mini review on skeeter syndrome or large local allergy to mosquito bites. J Egypt Soc Parasitol 47:415–424. https://doi.org/10.21608/jesp.2017.77796
Simons F, Estelle R, Peng Z (1999) Skeeter syndrome. J Allergy Clin Immunol 104:705–707. https://doi.org/10.1016/s0091-6749(99)70348-9
Sur R, Nigam A, Grote D, Liebel F, Southall MD (2008) Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity. Arch Dermatol Res 300:569–574. https://doi.org/10.1007/s00403-008-0858-x
Montag A (2021) Diseases caused by arthropods. Braun-Falco’S dermatology 1–45
Brummer-Korvenkontio H, Palosuo T, François G, Reunala T (1997) Characterization of Aedes communis, Aedes aegypti and Anopheles stephensi mosquito saliva antigens by immunoblotting. Int Arch Allergy Immunol 112:169–174. https://doi.org/10.1159/000237450
Kearney EA, Agius PA, Chaumeau V, Cutts JC, Simpson JA, Fowkes FJ (2021) Anopheles salivary antigens as serological biomarkers of vector exposure and malaria transmission: a systematic review with multilevel modelling. Elife. https://doi.org/10.7554/eLife.73080
Seda J, Horrall S (2019) Mosquito bites. StatPearls Publishing, Europe PMC
Cerio R, Dohil M, Jeanine D, Magina S, Mahé E, Stratigos AJ (2010) Mechanism of action and clinical benefits of colloidal oatmeal for dermatologic practice. J Drugs Dermatol 9:1116–1120
Ma L, Chen M, Fa Z, Pan W, Liao W, Gao XH, Huo W, Yang Y, Chen HD, Holahan HM, Laureano AC, Schwartz RA, Chen X, Anstey A, Bugert J, Chiu TM, Tsai YG., Nanda S, Lim HW, Wang WH (2016) Skin diseases caused by factors from the environment. Practical immunodermatology 145–198
Johnson J (2019) Skeeter syndrome: treatments and home remedies. https://www.medicalnewstoday.com/articles/325405
Golden DBK, Kelly D, Hamilton RG, Craig TJ (2009) Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol 123:1371–1375. https://doi.org/10.1016/j.jaci.2009.03.017
Meucci E, Radice A, Fassio F, Iorno MLC, Macchia D (2021) Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy. Clin Case Rep. https://doi.org/10.1002/ccr3.4935
Manning JE, Oliveira F, Coutinho-Abreu IV, Herbert S, Meneses C, Kamhawi S, Baus HA, Han A, Czajkowski L, Rosas LA, Cervantes-Medina A, Athota R, Reed S, Mateja A, Hunsberger S, James E, Pleguezuelos O, Stoloff G, Valenzuela JG, Memoli MJ (2020) Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial. The Lancet 395:1998–2007. https://doi.org/10.1016/S0140-6736(20)31048-5
Park SS, Heo EY, Kim DK, Chung HS, Lee CH (2015) The association of BCG vaccination with atopy and asthma in adults. Int J Med Sci 12:668–673. https://doi.org/10.7150/ijms.12233
Vaishnav N, Gupta A, Paul S, John GJ (2014) Overview of computational vaccinology: vaccine development through information technology. J Appl Genet 56:381–391. https://doi.org/10.1007/s13353-014-0265-2
Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308–311. https://doi.org/10.1093/nar/29.1.308
UNIPROT Consortium (2015) UniProt: a hub for protein information. Nucleic Acids Res 43:D204–D212
Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform 8:1–7. https://doi.org/10.1186/1471-2105-8-4
Dimitrov I, Bangov I, Flower DR, Doytchinova I (2014) AllerTOP v. 2-a server for in silico prediction of allergens. J Mol Model 20:1–6. https://doi.org/10.1007/s00894-014-2278-5
Sharma N, Naorem LD, Jain S, Raghava GPS (2022) ToxinPred2: an improved method for predicting toxicity of proteins. Brief Bioinform 23:bbac174. https://doi.org/10.1093/bib/bbac174
Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S, Madden TL (2008) NCBI BLAST: a better web interface. Nucleic Acids Res 1:W5-9. https://doi.org/10.1093/nar/gkn201
Fleri W, Paul S, Dhanda SK, Mahajan S, Xu X, Peters B, Sette A (2017) The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design. Front Immunol. https://doi.org/10.3389/fimmu.2017.00278
Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 1978:45–148. https://doi.org/10.1002/9780470122921.ch2
Emini EA, Hughes JV, Perlow DS, Boger J (1985) Induction of hepatitis a virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55:836–839. https://doi.org/10.1128/JVI.55.3.836-839.1985
Karplus PA, Schulz GE (1985) Prediction of chain flexibility in proteins. Sci Nat 72:212–213. https://doi.org/10.1007/BF01195768
Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172–174. https://doi.org/10.1016/0014-5793(90)80535-q
Parker JMR, Guo D, Hodges RS (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and x-ray-derived accessible sites. Biochemistry 25:5425–5432. https://doi.org/10.1021/bi00367a013
Ponomarenko JV, Bourne PE (2007) Antibody-protein interactions: benchmark datasets and prediction tools evaluation. BMC Struct Biol 7:64. https://doi.org/10.1186/1472-6807-7-64
Ponomarenko J, Bui HH, Li W, Fusseder N, Bourne PE, Sette A, Peters B (2008) ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. https://doi.org/10.1186/1471-2105-9-514
Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, Wheeler DK, Sette A, Peters B (2018) The immune epitope database (IEDB): 2018 update. Nucleic Acids Res 47:D339–D343. https://doi.org/10.1093/nar/gky1006
Nielsen M, Lundegaard C, Worning P, Lauemøller SL, Lamberth K, Buus S, Brunak S, Lund O (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Prot Sci 12:1007–1017. https://doi.org/10.1110/ps.0239403
Nielsen M, Lund O (2009) NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinform. https://doi.org/10.1186/1471-2105-10-296
Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Consortium OSDD, Raghava GP (2013) In silico approach for predicting toxicity of peptides and proteins. PLoS ONE 13:e73957. https://doi.org/10.1371/journal.pone.0073957
Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A (2006) Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinform 7:153. https://doi.org/10.1186/1471-2105-7-153
Sánchez MF, Els-Heindl S, Beck-Sickinger AG, Wieneke R, Tampé R (2021) Photoinduced receptor confinement drives ligand-independent GPCR signaling. Science 26:eabb7657. https://doi.org/10.1126/science.abb7657
Naveed M, Makhdoom SI, Ali U, Jabeen K, Aziz T, Khan AA, Jamil S, Shahzad M, Alharbi M, Alshammari A (2022) Immunoinformatics approach to design multi-epitope-based vaccine against machupo virus taking viral nucleocapsid as a potential candidate. Vaccines 10:1732. https://doi.org/10.3390/vaccines10050664
Naveed M, Ali U, Karobari MI, Ahmed N, Mohamed RN, Abullais SS, Kader MA, Marya A, Messina P, Scardina GA (2022) A vaccine construction against COVID-19-associated mucormycosis contrived with immunoinformatics-based scavenging of potential mucoralean epitopes. Vaccines 10:664. https://doi.org/10.3390/vaccines10050664
Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein Identification and analysis tools on the ExPASy server. The proteomics protocols handbook 571–607
Magnan CN, Randall A, Baldi P (2009) SOLpro: accurate sequence-based prediction of protein solubility. Bioinformatics 25:2200–2207. https://doi.org/10.1093/bioinformatics/btp386
Shende G, Haldankar H, Barai RS, Bharmal MH, Shetty V, Idicula-Thomas S (2017) PBIT: pipeline builder for identification of drug targets for infectious diseases. Bioinformatics 33:929–931. https://doi.org/10.1093/bioinformatics/btw760
McGuffin LJ, Bryson K, Jones DT (2000) The PSIPRED protein structure prediction server. Bioinformatics 16:404–405. https://doi.org/10.1093/bioinformatics/16.4.404
Rapin N, Lund O, Castiglione F (2011) Immune system simulation online. Bioinformatics 27:2013–2014. https://doi.org/10.1093/bioinformatics/btr335
Du Z, Su H, Wang W, Ye L, Wei H, Peng Z, Anishchenko I, Baker D, Yang J (2021) The trRosetta server for fast and accurate protein structure prediction. Nat Protoc 16:5634–5651. https://doi.org/10.1038/s41596-021-00628-9
Ko J, Park H, Heo L, Seok C (2012) GalaxyWEB server for protein structure prediction and refinement. Nucleic Acids Res 40:W294–W297. https://doi.org/10.1093/nar/gks493
Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, Greenbaum J, Lundegaard C, Sette A, Lund O, Bourne PE (2012) Immune epitope database analysis resource. Nucleic Acids Res 40:W525–W530. https://doi.org/10.1093/nar/gks438
Dombkowski AA, Sultana KZ, Craig DB (2013) Protein disulfide engineering. FEBS Lett 588:206–212. https://doi.org/10.1016/j.febslet.2013.11.024
López-Blanco JR, Aliaga JI, Quintana-Ortí ES, Chacón P (2014) iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res 42:W271–W276. https://doi.org/10.1093/nar/gku339
Desta IT, Porter KA, Xia B, Kozakov D, Vajda S (2020) Performance and its limits in rigid body protein-protein docking. Structure 28:1071-1081.e3. https://doi.org/10.1016/j.str.2020.06.006
Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow GV, Duarte JM, Dutta S, Fayazi M, Feng Z, Flatt JW, Ganesan SJ, Goodsell DS, Ghosh S, Kramer Green R, Guranovic V, Henry J, Hudson BP, Lawson CL, Liang Y (2021) RCSB protein data bank: celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D. Prot Sci 31:187–208. https://doi.org/10.1002/pro.4213
Leitner WW, Thalhamer J (2003) DNA vaccines for non-infectious diseases: new treatments for tumour and allergy. Expert Opin Biol Ther 3:627–638. https://doi.org/10.1517/14712598.3.4.627
Rousseau MC, Parent ME, St-Pierre Y (2008) Potential health effects from non-specific stimulation of the immune function in early age: the example of BCG vaccination. Pediatr Allergy Immunol 19:438–448. https://doi.org/10.1111/j.1399-3038.2007.00669.x
Pascolo S (2015) The messenger’s great message for vaccination. Expert Rev Vaccines 14:153–156. https://doi.org/10.1586/14760584.2015.1000871
Graham H (2020) Red, hot, and blistered. what is it? J Pediatr Surg Nurs 10:77–79. https://doi.org/10.1097/JPS.0000000000000288
Thapa SS, Basnyat B (2018) Common Bite—Bizarre Rash. Wilderness Environ Med 29:123–124. https://doi.org/10.1016/j.wem.2017.09.001
Ariano R, Panzani RC (2004) Efficacy and safety of specific immunotherapy to mosquito bites. Eur Ann Allergy Clin Immunol 36:131–138
Racioppi JV, Spielman A (1987) Secretory proteins from the salivary glands of adult Aedes aegypti mosquitoes. Insect Biochem 17:503–511. https://doi.org/10.1016/0020-1790(87)90010-2
Peng Z, Xu WW, Sham Y, Lam H, Sun D, Li C, Rasic NF, Guan Q, James AA, Simons FER (2016) Mosquito salivary allergen Aed a 3: cloning, comprehensive molecular analysis, and clinical evaluation. Allergy 71:621–628. https://doi.org/10.1111/all.12812
Martini S, Nielsen M, Peters B, Sette A (2020) The immune epitope database and analysis resource program 2003–2018: reflections and outlook. Immunogenetics 72:57–76. https://doi.org/10.1007/s00251-019-01137-6
Naveed M, Sheraz M, Amin A, Waseem M, Aziz T, Khan AA, Ghani M, Shahzad M, Alruways MW, Dablool AS, Elazzazy AM, Almalki AA, Alamri AS, Alhomrani M (2022) Designing a novel peptide-based multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant providencia heimbachae. Vaccines 10:1300. https://doi.org/10.3390/vaccines10081300
Peng Z, Simons FER (2004) Mosquito allergy: immune mechanisms and recombinant salivary allergens. Int Arch Allergy Immunol 133:198–209. https://doi.org/10.1159/000076787
Hema K, Priyadarshini IV (2015) Identification of putative drug targets and vaccine candidates for pathogens causing atherosclerosis. Biochem Anal Biochem. https://doi.org/10.4172/2161-1009.1000175
Rawal K, Sinha R, Abbasi BA, Chaudhary A, Nath SK, Kumari P, Preeti P, Saraf D, Singh S, Mishra K, Gupta P, Mishra A, Sharma T, Gupta S, Singh P, Sood S, Subramani P, Dubey AK, Strych U, Hotez PJ (2021) Identifying vaccine targets in pathogens and designing a vaccine using computational approaches. Sci Rep. https://doi.org/10.1101/2020.03.20.000141
Singh H, Ansari HR, Raghava G (2013) Improved method for linear B-cell epitope prediction using antigen’s primary sequence. PLoS ONE 8:e62216. https://doi.org/10.1371/journal.pone.0062216
Curin M, Khaitov M, Karaulov A, Namazova-Baranova L, Campana R, Garib V, Valenta R (2018) Next-generation of allergen-specific immunotherapies: molecular approaches. Curr Allergy Asthma Rep. https://doi.org/10.1007/s11882-018-0790-x
Kowalewicz-Kulbat M, Locht C (2021) BCG for the prevention and treatment of allergic asthma. Vaccines 39:7341–7352. https://doi.org/10.1016/j.vaccine.2021.07.092
Yoshimoto T, Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K (2007) IL-27 Suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol 179:4415–4423. https://doi.org/10.4049/jimmunol.179.7.4415
Christy AJ, Dharman K, Dhandapaani G, Palaniyandi K, Gupta UD, Gupta P, Ignacimuthu S, Narayanan S (2012) Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice. Vaccines 30:1364–1370. https://doi.org/10.1016/j.vaccine.2011.12.059
Sayers S, Ulysse G, Xiang Z, He Y (2012) Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development. J Biomed Biotechnol 2012:1–13. https://doi.org/10.1155/2012/831486
Chen X, Zaro JL, Shen WC (2013) Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev 65:1357–1369. https://doi.org/10.1016/j.addr.2012.09.039
Tompa P (2002) Intrinsically unstructured proteins. Trends Biochem Sci 27:527–533. https://doi.org/10.1016/s0968-0004(02)02169-2
Magombedze G, Eda S, Ganusov VV (2014) Competition for antigen between Th1 and Th2 responses determines the timing of the immune response switch during Mycobaterium avium subspecies paratuberulosis Infection in Ruminants. PLoS Comput Biol 10:e1003414. https://doi.org/10.1371/journal.pcbi.1003414
DiToro D, Basu R (2021) Emerging complexity in CD4+T lineage programming and its implications in colorectal cancer. Front Immunol. https://doi.org/10.3389/fimmu.2021.694833
León B, Ballesteros-Tato A (2021) Modulating Th2 cell immunity for the treatment of asthma. Front Immunol. https://doi.org/10.3389/fimmu.2021.637948
Naveed M, Ain N, Aziz T, Javed K, Ishfaq H, Khalil S, Alharbi M, Alshammari A, Alasmari AF (2023) A pharmacophore screening approach of homeopathic phenols for a renovated design of fragment-optimized Bauhiniastatin-1 as a drug against acromegaly. Eur Rev Med Pharmacol Sci 27:5530–5541. https://doi.org/10.26355/eurrev_202306_32790
Naveed M, Hassan J, Aziz T, Ali U, Rana IK, Khan UA, Fakhrul H, Alharbi M, Alshammari A, Alasmari AF (2023) A one-health approach to design an mRNA-based vaccine candidate against the lumpy skin disease virus as an alternative to live-attenuated vaccines. Eur Rev Med Pharmacol Sci 27:6401–6413. https://doi.org/10.26355/eurrev_202307_33000
Bachmann MF, Jennings GT (2010) Vaccine delivery: a matter of size, geometry, kinetics, and molecular patterns. Nat Rev Immunol 10:787–796. https://doi.org/10.1038/nri2868
Ahmed N, Zeshan B, Naveed M, Afzal M, Mohamed M (2019) Antibiotic resistance profile in relation to virulence genes fimH, hlyA and usp of uropathogenic E. coli isolates in Lahore. Trop Biomed 36:559–568
Muñoz-Caro T, Gibson AJ, Conejeros I, Werling D, Taubert A, Hermosilla C (2021) The role of TLR2 and TLR4 in recognition and uptake of the apicomplexan parasite Eimeria bovis and their effects on NET formation. Pathogens 10:118. https://doi.org/10.3390/pathogens10020118
Mehwish H, Uzma S, Yasmeen R, Muhammad KA, Khalid M, Sumaira N, Tariq A, Metab A, Abdulrahman A, Abdullah FA (2023) Determining the 3-substituted coumarins inhibitory potential against the HslV protease of E. coli. Eur Rev Med Pharmacol Sci 27:9160–9168. https://doi.org/10.26355/eurrev_202310_33945
Naveed M, Mahmood S, Aziz T, Azeem A, Hussain I, Waseem M, Ali A, Alharbi M, Alshammari A, Alasmari A (2023) Designing a novel chimeric multi-epitope vaccine subunit against Staphylococcus argenteus through artificial intelligence approach integrating pan-genome analysis, in vitro identification, and immunogenicity profiling. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2023.2256881
Hussain N, Mumtaz M, Adil M, Ali Nadeem A, Sarwar A, Aziz T, Alharbi M, Alshammari A, Alasmari AF, Alharbi ME (2023) Investigation of VEGF (rs 699947) polymorphism in the progression of Rheumatoid Arthritis (RA) and in-silico nanoparticle drug delivery of potential phytochemicals to cure RA. Acta Biochim Pol 5:591–598. https://doi.org/10.18388/abp.2020_6654
Naveed M, Ahmed I, Khalid N, Mumtaz AS (2014) Bioinformatics based structural characterization of glucose dehydrogenase (gdh) gene and growth promoting activity of Leclercia sp. QAU-66. Braz J Microbiol 45:603–611. https://doi.org/10.1590/s1517-83822014000200031
Acknowledgements
The authors are thankful to the Researchers Supporting Project number (RSP2024R462), King Saud University, Riyadh, Saudi Arabia.
Funding
No external funding was received.
Author information
Authors and Affiliations
Contributions
Conceptualization, MN, UA, RN, MMK. and TA; methodology, MMK; software, UA; validation, SM, and TA; formal analysis, MN, UA, RN, MMK and TA; investigation, UA and SM; resources, MN; data curation, ASA, MA, and RN; writing—original draft preparation, MA and AAS; writing—review and editing, THA; visualization, TA and RN; supervision, MN and TA; project administration, MMK; funding acquisition, TA.
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare no conflict of interest.
Ethical Approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Naveed, M., Ali, U., Aziz, T. et al. An Aedes–Anopheles Vaccine Candidate Supplemented with BCG Epitopes Against the Aedes and Anopheles Genera to Overcome Hypersensitivity to Mosquito Bites. Acta Parasit. 69, 483–504 (2024). https://doi.org/10.1007/s11686-023-00771-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11686-023-00771-1